VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 701 filers reported holding VANECK VECTORS ETF TR in Q2 2021. The put-call ratio across all filers is 1.04 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,106,821 | +158189.8% | 226,935 | +68.6% | 0.72% | +24.3% |
| Q4 2022 | $3,858 | -99.9% | 134,600 | -50.7% | 0.58% | -62.5% |
| Q3 2022 | $6,585,000 | -67.1% | 273,000 | -56.3% | 1.54% | -73.6% |
| Q4 2021 | $20,025,000 | -27.8% | 625,200 | -33.5% | 5.83% | -30.9% |
| Q3 2021 | $27,725,000 | -99.9% | 940,800 | +49.2% | 8.44% | +45.4% |
| Q1 2021 | $20,491,250,000 | +203065.3% | 630,500 | +125.2% | 5.80% | +75.8% |
| Q4 2020 | $10,086,000 | – | 280,000 | – | 3.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Harbor Financial Group, LLC | 2,418,400 | $77,461,000 | 26.62% |
| Brevan Howard Capital Management LP | 1,000,000 | $32,030,000 | 23.21% |
| Windmill Hill Asset Management Ltd | 844,600 | $27,053,000 | 19.48% |
| Memorial Sloan Kettering Cancer Center | 738,500 | $23,654,000 | 14.86% |
| New Harbor Financial Group, LLC | 1,286,391 | $41,203,000 | 14.16% |
| Eschler Asset Management LLP | 300,000 | $9,609,000 | 12.30% |
| Hollow Brook Wealth Management LLC | 712,669 | $22,827,000 | 11.71% |
| Grand Central Investment Group | 284,547 | $9,114,000 | 10.90% |
| Baymount Management LP | 500,000 | $16,015,000 | 9.54% |
| Nokomis Capital, L.L.C. | 512,628 | $16,419,000 | 6.93% |